Financhill
Back

Catalent Quote, Financials, Valuation and Earnings

Catalent Price Quote

$63.48

Catalent Key Stats

Sell
50
Catalent (CTLT) is a Sell

Day range:
$63.44 - $63.50
52-week range:
$42.07 - $63.50
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.61
P/B ratio:
3.25%

Volume:
13.6M
Avg. volume:
2.8M
1-year change:
53.04%
Market cap:
$11.5B
Revenue:
$4.4B
EPS:
$-2.27

How Much Does Catalent Make?

Data Unavailable

Is Catalent Growing As A Company?

Data Unavailable

Catalent Stock Price Performance

  • Did Catalent Stock Go Up Last Month?
    Catalent share price went up by 7.41% last month
  • Did CTLT's Share Price Rise Over The Last Year?
    CTLT share price rose by 53.04% over the past 1 year

What Is Catalent 52-Week High & Low?

  • What Is Catalent’s 52-Week High Share Price?
    Catalent has traded as high as $63.50 over the past 52 weeks
  • What Is Catalent’s 52-Week Low Share Price?
    Catalent has traded as low as $42.07 over the past 52 weeks

Catalent Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Catalent?

Data Unavailable

Is Catalent Cash Flow Positive?

Data Unavailable

Catalent Return On Invested Capital

Data Unavailable

Catalent Earnings Date & Stock Price

  • What Is Catalent's Stock Price Today?
    A single share of CTLT can be purchased today for 63.48
  • What Is Catalent’s Stock Symbol?
    Catalent trades on the nyse under the ticker symbol: CTLT
  • When Is Catalent’s Next Earnings Date?
    The next quarterly earnings date for Catalent is scheduled on February 7, 2025
  • When Is CTLT's next ex-dividend date?
    Catalent's next ex-dividend date is December 22, 2024
  • How To Buy Catalent Stock?
    You can buy Catalent shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Catalent Competitors

  • Who Are Catalent's Competitors?
    Below is a list of companies who compete with Catalent or are related in some way:
    • Boston Scientific Corp (BSX)
    • Eli Lilly and Co (LLY)
    • MAIA Biotechnology Inc (MAIA)
    • Merck & Co Inc (MRK)
    • Pfizer Inc (PFE)

Catalent Dividend Yield

Data Unavailable

Catalent Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -224.02%
Revenue: 4.18% -3.5%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 63.50
Upside from Last Price: 0.03%

Major Shareholders

Data Unavailable